An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects
Clinical trial NCT02190747 · COMPLETED
Trial details
- NCT number
- NCT02190747
- Sponsor
- Clementia Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-14
- Primary completion
- 2016-05-23
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.